Somatic Mutations in Myelodysplastic Syndrome Patients in the Context of Allogeneic Stem Cell Transplantation

Myelodysplastic syndrome (MDS) is a heterogeneous group of myeloid disorders. Allogeneic stem cell transplantation (alloSCT) is the therapeutic approach with a known curative potential for patients with MDS, which allows long-term disease control to be achieved. Despite advances in transplantation t...

Full description

Bibliographic Details
Main Authors: Olga Blau, Rolf Schwarzer, Igor Wolfgang Blau
Format: Article
Language:English
Published: European Medical Journal 2016-11-01
Series:European Medical Journal Oncology
Subjects:
Online Access:https://www.emjreviews.com/oncology/article/somatic-mutations-in-myelodysplastic-syndrome-patients-in-the-context-of-allogeneic-stem-cell-transplantation/